VERU - Veru - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

VERU is currently covered by 3 analysts with an average price target of $8.04. This is a potential upside of $7.55 (1540.82%) from yesterday's end of day stock price of $0.49.

Veru's activity chart (see below) currently has 54 price targets and 49 ratings on display. The stock rating distribution of VERU is 93.75% BUY and 6.25% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 34.08% with an average time for these price targets to be met of 225.4 days.

Highest price target for VERU is $3, Lowest price target is $3, average price target is $3.

Most recent stock forecast was given by YI CHEN from HCWAINWRIGHT on 02-Jan-2025. First documented stock forecast 19-Mar-2019.

Best performing analysts who are covering VERU - Veru:

Chris Howerton Leland Gershell Brandon Folkes Yi Chen Kumaraguru Raja

Currently out of the existing stock ratings of VERU, 15 are a BUY (93.75%), 1 are a HOLD (6.25%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$3

$1.79 (147.93%)

$3

4 months 20 days ago
(02-Jan-2025)

4/16 (25%)

$2.35 (361.54%)

233

Buy

$5

$3.79 (313.22%)

1 years 1 months 7 days ago
(15-Apr-2024)

3/16 (18.75%)

$3.47 (226.80%)

331

Hold

$1

$-0.21 (-17.36%)

$55

1 years 11 months 15 days ago
(07-Jun-2023)

3/5 (60%)

$-0.22 (-18.03%)

312

Buy

$22

$20.79 (1718.18%)

$30

2 years 5 months 17 days ago
(05-Dec-2022)

2/6 (33.33%)

$16.18 (278.01%)

191

Buy

$31

$29.79 (2461.98%)

$27

3 years 4 days ago
(18-May-2022)

1/3 (33.33%)

$15.99 (106.53%)

60

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is VERU (Veru) average time for price targets to be met?

On average it took 225.4 days on average for the stock forecasts to be realized with a an average price target met ratio 34.08

Which analyst has the current highest performing score on VERU (Veru) with a proven track record?

CHRIS HOWERTON

Which analyst has the current lower performing score on VERU (Veru) with a proven track record?

KUMARAGURU RAJA

Which analyst has the most public recommendations on VERU (Veru)?

Chris Howerton has 8 price targets and 3 ratings on VERU

Which analyst is the currently most bullish on VERU (Veru)?

Kumaraguru Raja with highest potential upside - $29.79

Which analyst is the currently most reserved on VERU (Veru)?

Chris Howerton with lowest potential downside - -$0.21

Veru in the News

Veru Participates in a Virtual Investor KOL Connect Segment

— Moderated discussion with preeminent obesity expert, Louis J. Aronne, MD, FACP and Mitchell Steiner, M.D., F.A.C.S, President, CEO, and Founder, of Veru — MIAMI, FL, May 08, 2025 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases,...

Veru Reports Fiscal 2025 Second Quarter Financial Results and Clinical Program Progress

–Unblinded safety data from Phase 2b QUALITY study expected in the second quarter of calendar 2025 — –Topline efficacy and safety data for Phase 2b extension maintenance study expected in the second quarter of calendar 2025 — –With positive Phase 2b QUALITY study, Veru plans for end of Phase 2 meeting with FDA to discuss...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?